Eli Lilly to present new data on Emgality, Lasmiditan at AAN annual meeting Farhat Nasim5 May 2019 4:30 AM GMTEmgality is also currently under Priority Review by the FDA as an investigational drug for the preventive treatment of episodic cluster headache in...